glp 1 drug mounjaro FDA approves new version of diabetes to be sold for weight loss GLP-1 Multi-District Litigation | Updates

Dulaglutide is a long-acting GLP-1RA used for T2DM with demonstrated cardiovascular benefits.[10] Liraglutide, another long-acting GLP-1RA, is used for T2DM and obesity management and is under investigation for Alzheimers disease and metabolic-associated hepatic steatosis.[4] Lixisenatide, a short-acting GLP-1RA, shows comparable efficacy to exenatide and liraglutide for T2DM management, and is now combined with insulin glargine.[23] Semaglutide, available in injectable and oral forms, has demonstrated benefits in promoting weight loss, reducing risk of cardiovascular events, and slowing progression of diabetic CKD.[24] Finally, tirzepatide is a dual agonist for receptors of GLP and glucose-dependent insulinotropic polypeptide (GIP), a hormone released from the intestines in response to macronutrients.[25] These two mechanisms of action have synergistic glucose-lowering and weight loss effects with lower side effect rates than other GLP-1RAs.[25] Tirzepatide has also been shown to result in blood pressure reduction, obstructive sleep apnea control, and improved cholesterol in T2DM patients.[5] Table

J.WestR

The bigger picture: GLP-1 therapies are driving innovation at the intersection of endocrinology, cardiology, and obesity managementand reshaping pharma pipelines globally

Mitopure (Urolithin A) by Timeline offers a scientifically backed approach to support the health of our muscles and our skin

M., DAlessio, D., Grewal, D

GLP-1 is a naturally occurring hormone that influences our blood sugar levels, insulin levels, and feelings of hunger